Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S M Marcy

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
The Pediatric Infectious Disease Journal|March 1, 1991
Leukocyte responses to diphtheria-tetanus-pertussis and diphtheria-tetanus immunizationD A Blumberg, K Lewis, J D Cherry, et al.
The New England Journal of Medicine|January 28, 1971
Birth weight and genital mycoplasmas in pregnancyP Braun, Y H Lee, J O Klein, et al.
The Pediatric Infectious Disease Journal|September 1, 1988
Consensus: management of Salmonella infection in the first year of lifeJ W Geme, H L Hodes, S M Marcy, et al.
The Pediatric Infectious Disease Journal|October 20, 2001
Safety and immunogenicity of a pentavalent diphtheria, tetanus, pertussis, hepatitis B and polio combination vaccine in infantsS H Yeh, J I Ward, S Partridge, et al.
Pediatrics|October 3, 2003
Risk of anaphylaxis after vaccination of children and adolescentsKari Bohlke, Robert L Davis, S M Marcy, et al.
The Journal of Pediatrics|February 1, 1995
Enhanced antibody responses in infants given different sequences of heterogeneous Haemophilus influenzae type b conjugate vaccinesD P Greenberg, J M Lieberman, S M Marcy, et al.
Vaccine|June 1, 1996
Safety and immunogenicity of a recombinant hepatitis B vaccine administered to infants at 2, 4 and 6 months of age. The Kaiser-UCLA Vaccine Study GroupD P Greenberg, C M Vadheim, S M Marcy, et al.
Pediatrics|March 1, 1990
Persistence of antibody and booster responses to reimmunization with Haemophilus influenzae type b polysaccharide and polysaccharide diphtheria toxoid conjugate vaccines in children initially immunized at 15 to 24 months of ageC D Berkowitz, J I Ward, C E Chiu, et al.
The Pediatric Infectious Disease Journal|July 1, 1996
Comparative safety and immunogenicity of two recombinant hepatitis B vaccines given to infants at two, four and six months of ageD P Greenberg, C M Vadheim, V K Wong, et al.
The Pediatric Infectious Disease Journal|December 6, 2001
Prospective, randomized, placebo-controlled evaluation of the safety and immunogenicity of three lots of intranasal trivalent influenza vaccine among young childrenK M Zangwill, J Droge, P Mendelman, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
The Pediatric Infectious Disease Journal|March 1, 1991
Leukocyte responses to diphtheria-tetanus-pertussis and diphtheria-tetanus immunizationD A Blumberg, K Lewis, J D Cherry, et al.
The New England Journal of Medicine|January 28, 1971
Birth weight and genital mycoplasmas in pregnancyP Braun, Y H Lee, J O Klein, et al.
The Pediatric Infectious Disease Journal|September 1, 1988
Consensus: management of Salmonella infection in the first year of lifeJ W Geme, H L Hodes, S M Marcy, et al.
The Pediatric Infectious Disease Journal|October 20, 2001
Safety and immunogenicity of a pentavalent diphtheria, tetanus, pertussis, hepatitis B and polio combination vaccine in infantsS H Yeh, J I Ward, S Partridge, et al.
Pediatrics|October 3, 2003
Risk of anaphylaxis after vaccination of children and adolescentsKari Bohlke, Robert L Davis, S M Marcy, et al.
The Journal of Pediatrics|February 1, 1995
Enhanced antibody responses in infants given different sequences of heterogeneous Haemophilus influenzae type b conjugate vaccinesD P Greenberg, J M Lieberman, S M Marcy, et al.
Vaccine|June 1, 1996
Safety and immunogenicity of a recombinant hepatitis B vaccine administered to infants at 2, 4 and 6 months of age. The Kaiser-UCLA Vaccine Study GroupD P Greenberg, C M Vadheim, S M Marcy, et al.
Pediatrics|March 1, 1990
Persistence of antibody and booster responses to reimmunization with Haemophilus influenzae type b polysaccharide and polysaccharide diphtheria toxoid conjugate vaccines in children initially immunized at 15 to 24 months of ageC D Berkowitz, J I Ward, C E Chiu, et al.
The Pediatric Infectious Disease Journal|July 1, 1996
Comparative safety and immunogenicity of two recombinant hepatitis B vaccines given to infants at two, four and six months of ageD P Greenberg, C M Vadheim, V K Wong, et al.
The Pediatric Infectious Disease Journal|December 6, 2001
Prospective, randomized, placebo-controlled evaluation of the safety and immunogenicity of three lots of intranasal trivalent influenza vaccine among young childrenK M Zangwill, J Droge, P Mendelman, et al.
Pageof 6